How did BLRX's Q4 2023 earnings surprise impact its stock?

BioLineRx (BLRX) experienced a significant decline in its stock following the release of the Q4 2023 earnings report, with a decrease of 5.06% on November 9, 2023. This decline suggests that the market may have had concerns or reacted negatively to the information presented in the earnings report. |code|Ticker|Name|Date|Revenue Surprise|Revenue Surprise YoY|market_code| |---|---|---|---|---|---|---| |BLRX|BLRX.O|BioLineRx|2023 Q4|3850000||186| |BLRX|BLRX.O|BioLineRx|2024 Q1|5030000||186| |BLRX|BLRX.O|BioLineRx|2024 Q2|1463000||186| |BLRX|BLRX.O|BioLineRx|2024 Q3|580000||186| |code|Ticker|Name|Date|Percentage Change|market_code| |---|---|---|---|---|---| |BLRX|BLRX.O|BioLineRx|20231002|-3.2967|186| |BLRX|BLRX.O|BioLineRx|20231003|-9.0909|186| |BLRX|BLRX.O|BioLineRx|20231004|-9.375|186| |BLRX|BLRX.O|BioLineRx|20231005|5.5172|186| |BLRX|BLRX.O|BioLineRx|20231006|-2.6144|186| |BLRX|BLRX.O|BioLineRx|20231009|4.698|186| |BLRX|BLRX.O|BioLineRx|20231010|4.1667|186| |BLRX|BLRX.O|BioLineRx|20231011|-7.6923|186| |BLRX|BLRX.O|BioLineRx|20231012|2.6667|186| |BLRX|BLRX.O|BioLineRx|20231013|3.8961|186|